First ever phase 1 trial of genital chlamydia vaccine finds it is safe and provokes immune response
Chlamydia is the most common sexually transmitted bacterial infection worldwide, but national screening programmes and antibiotic treatment have failed to decrease infection incidences.
Aug 13, 2019
1
6